在慢性心力衰竭中支持药物坚持的NPS MedicineWise应用:可接受性和可行性试点研究
Jessica Chapman-Goetz1, Nerida Packham2, Kitty Yu3
1Clinical and Health Sciences, University of South Australia, Adelaide, SA, Australia.
Frontiers in digital health
|November 30, 2023
概括
一个移动健康应用程序与药剂师支持相结合,改善了心力衰竭患者的药物坚持. 这种干预是可行的和有价值的管理心力衰竭 (HF) 治疗.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 数字健康数字健康
背景情况:
- 心力衰竭 (HF) 是一个日益增长的全球健康挑战.
- 尽管目前的药物治疗,HF发病率和死亡率仍然很高.
- 药物不服药是有效控制高频率的重要障碍.
研究的目的:
- 为了评估NPS MedicineWise剂量提醒应用程序的可接受性,可行性和价值.
- 评估一个分层的,由药剂师领导的干预措施,以改善HF患者的药物坚持.
- 为了确定应用程序对药物管理中的自我有效性的影响.
主要方法:
- 这是一项前性,单盲,随机对照试验,涉及55名HF患者.
- 参与者被分配到使用应用程序的干预组或接受标准护理的对照组.
- 用适当药物使用量表 (SEAMS) 的自我效能度量来衡量坚持支持.
主要成果:
- 干预参与者从基线到6个月的SEAMS分数显著改善.
- 大约一半的用户报告说,使用该应用程序可以更好地管理HF和药物.
- 在应用程序消息和药剂师干预方面报告了高度满意度.
结论:
- 整合到一个分层的,由药剂师领导的干预中,MedicineWise应用程序是可行的和有价值的,用于提高HF药物坚持.
- 移动医疗干预措施显示出实际潜力,可以支持HF患者的治疗坚持.
- 研究结果为临床医生在HF护理中实施数字健康工具提供了现实世界的见解.
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
436
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
436
01:26Heart Failure Drugs: Inotropic Agents
594
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
594
01:22Heart Failure Drugs: β-Blockers
342
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
342
01:28Drug Therapy
45
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
45
01:22Heart Failure Drugs: Diuretics
396
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
396
01:30Chronic Obstructive Pulmonary Disease-V: Nursing Management
3.9K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
3.9K